Buy Erlocip 150 mg, manufactured by Cipla, contains "Erlotinib" as an active ingredient. It belongs to a class of medicines called tyrosine kinase inhibitor. It is a prescription cancer drug and should not be taken without a doctor's consent. Do not share this medicine with others because it can cause serious side effects to people until the condition is not monitored by health care professionals.